Acadia Pharmaceuticals (ACAD) EBT Margin Growth (5y) (2015 - 2026)
Acadia Pharmaceuticals (ACAD) EBT Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Acadia Pharmaceuticals | 4.23 Bn | 3.38 Bn | 243.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,383.00 |
| Dec 31, 2025 | 6,409.00 |
| Sep 30, 2025 | 8,638.00 |
| Jun 30, 2025 | 5,311.00 |
| Mar 31, 2025 | 10,911.00 |
| Dec 31, 2024 | 11,558.00 |
| Sep 30, 2024 | 6,016.00 |
| Jun 30, 2024 | 8,096.00 |
| Mar 31, 2024 | 14,510.00 |
| Dec 31, 2023 | 12,708.00 |
| Sep 30, 2023 | 8,132.00 |
| Jun 30, 2023 | 11,433.00 |
| Mar 31, 2023 | 7,188.00 |
| Dec 31, 2022 | 12,825.00 |
| Sep 30, 2022 | 16,132.00 |
| Jun 30, 2022 | 19,505.00 |
| Mar 31, 2022 | 47,662.00 |
| Dec 31, 2021 | 62,185.00 |
| Sep 30, 2021 | 139,155.00 |
| Jun 30, 2021 | 7.57 Mn |